Hypertension
Conference Coverage
Eyes on ESC ‘21: Hope for EMPEROR-Preserved, guidelines remade
But the congress will feature far more than, potentially, results the heart failure world has been longing to see and a raft of new guidelines....
From the Journals
Flavonoid-rich foods, aided by gut bacteria, tied to lower BP
“Incorporating flavonoid-rich foods into the diet can have clinically relevant reductions in systolic blood pressure and pulse pressure, and a...
From the Journals
Obesity leads to depression via social and metabolic factors
Consider the biological consequences of having a higher BMI and the social implications when treating patients with obesity.
From the Journals
Aerobic exercise reduces BP in resistant hypertension
For patients whose hypertension is drug-resistant, aerobic exercise may be part of the solution, a small randomized trial suggests.
From the Journals
Despite retraction, study using fraudulent Surgisphere data still cited
This despite a quick and widely publicized retraction of the COVID-19 cardiovascular study and stratospheric fall of the health care analytics...
Conference Coverage
ESC heart failure guideline to integrate bounty of new meds
It has a simple answer to a seemingly complex issue: how to merge the newly approved with mainstay drug therapies. And it conditionally okays meds...
From the Journals
ARBs equal ACE inhibitors for hypertension, and better tolerated
Although ACE inhibitors are more commonly prescribed, new findings from almost 3 million patients support starting with ARBs as first-time...
From the Journals
In sickness and in health: Spouses can share risk for cardiac events
A married person’s CV history may predict future cardiac events in the spouse, possibly because the two tend to share lifestyle risk factors. But...
From the Journals
More on GRADE: Cognitive deficits linked to CV risk factors in T2D
Hyperlipidemia and hypertension predict modest cognitive impairment even in diabetes of limited duration, but one expert urges caution: “The...
From the Journals
Dapagliflozin safe, protective in advanced kidney disease
“This is now the absolute reassurance that we do not have to stop an SGLT2 inhibitor in people with eGFR< 30 mL/min for safety reasons” and...
From the Journals
‘Gold cards’ allow Texas docs to skip prior authorizations
Through this law, doctors in the state will spend less time getting approvals for treatments for their patients.